Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

2.9K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Serum Proteomic Profiling Implicates a Dysregulated Neurohormonal-Inflammatory Axis in Post-Fontan Sinus Tachycardia.

Journal of the American Heart Association·2026
Same author

Optimal Operative Strategies in Repair of Giant Coronary Artery Aneurysms: Case Presentation.

Surgical case reports·2026
Same author

Immersive Three-Dimensional Visualization as a Routine Tool for Complex Congenital Cardiac Surgical Planning: A Perspective.

Pediatric cardiology·2026
Same author

Successful thoracic endovascular aortic repair for complicated Stanford type B acute aortic dissection with acute renal failure and vascular remodelling after intervention: case report and 5-year follow-up.

European heart journal. Case reports·2026
Same author

[Non-anastomotic Pseudoaneurysm due to Sternal Wire Removal After Ascending Aorta Grafting:Report of a Case].

Kyobu geka. The Japanese journal of thoracic surgery·2026
Same author

Clinical outcomes of a novel sternal closure technique using tension-fixed titanium cables and a biodegradable poly-lactic acid mesh plate.

Journal of cardiothoracic surgery·2026

Related Experiment Video

Updated: May 4, 2026

Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor
11:22

Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor

Published on: June 14, 2011

16.8K

Vessel bioengineering.

Shuhei Tara1, Kevin A Rocco, Narutoshi Hibino

  • 1Nationwide Children's Hospital.

Circulation Journal : Official Journal of the Japanese Circulation Society
|December 17, 2013
PubMed
Summary

Tissue-engineered vascular grafts (TEVG) show promise for cardiovascular disease. However, small-diameter arterial TEVG (<6mm) face challenges, requiring collaboration for clinical success.

More Related Videos

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K
A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch
07:51

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

Published on: December 10, 2020

5.0K

Related Experiment Videos

Last Updated: May 4, 2026

Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor
11:22

Engineering Biological-Based Vascular Grafts Using a Pulsatile Bioreactor

Published on: June 14, 2011

16.8K
Generation and Grafting of Tissue-engineered Vessels in a Mouse Model
13:04

Generation and Grafting of Tissue-engineered Vessels in a Mouse Model

Published on: March 18, 2015

11.7K
A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch
07:51

A Multi-Cue Bioreactor to Evaluate the Inflammatory and Regenerative Capacity of Biomaterials under Flow and Stretch

Published on: December 10, 2020

5.0K

Area of Science:

  • Biomedical Engineering
  • Regenerative Medicine
  • Cardiovascular Research

Background:

  • Vascular bioengineering offers novel treatments for cardiovascular disease.
  • Tissue-engineered vascular grafts (TEVG) utilize biodegradable scaffolds and autologous cells for in situ neovascularization.
  • TEVG have shown clinical viability in congenital heart defect patients.

Purpose of the Study:

  • To review the development and challenges of tissue-engineered vascular grafts (TEVG) for arterial applications.
  • To highlight the requirements for arterial scaffolds and the role of cell sources in TEVG.
  • To identify barriers to the clinical translation of small-diameter arterial TEVG.

Main Methods:

  • Review of biodegradable synthetic polymers and natural materials for arterial scaffolds.
  • Analysis of various cell sources (somatic cells, stem cells) used in TEVG.
  • Examination of clinical effectiveness data for small-diameter arterial TEVG.

Main Results:

  • Biodegradable scaffolds, from synthetic polymers or natural materials, can meet arterial pressure requirements.
  • Diverse cell types are employed in TEVG, influencing tissue remodeling.
  • Clinical effectiveness of small-diameter arterial TEVG (<6mm) remains a significant challenge.

Conclusions:

  • Successful clinical translation of arterial TEVG requires overcoming challenges in small-diameter applications.
  • Interdisciplinary collaboration among biologists, engineers, and clinicians is essential for advancing TEVG technology.
  • Further research is needed to improve the performance and reliability of arterial TEVG.